Institutional investors purchased a net $3.5 million shares of NEO during the quarter ended September 2017, and now own 66.59% of the total float, a percentage that is typical for companies in the Medical/Nursing Services industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JANUS CAPITAL MANAGEMENT LLC Bought 1.2 Million shares of Neogenomics Inc
PHOCAS FINANCIAL CORP. Bought 514.1 Thousand shares of Neogenomics Inc
FALCON POINT CAPITAL LLC Bought 509.3 Thousand shares of Neogenomics Inc